Summary
Global Market Direct’s pharmaceuticals report, “Calzada Limited - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. It also gives a complete picture of the company’s future therapy areas of focus.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by Global Markets Direct’s team of industry experts.
Scope
- Calzada Limited - company overview including business description, key employees, and other facts.
- Review of current pipeline of Calzada Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, for the pharmaceutical markets across the globe.
- Product profiles for late stage and clinical stage products of Calzada Limited with complete description of the product’s developmental history, mechanism of action, clinical trials, major milestones and others.
- Recent updates of the Calzada Limited’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Calzada Limited’s strategic position with total access to a detailed intelligence on its product pipeline.
- Assess the growth potential of Calzada Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Calzada Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Calzada Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Calzada Limited and identify potential opportunities in those areas.
- Do deals with an understanding of the mergers and partnerships that have shaped the sector.
Global Market Direct’s pharmaceuticals report, “Calzada Limited - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. It also gives a complete picture of the company’s future therapy areas of focus.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by Global Markets Direct’s team of industry experts.
Scope
- Calzada Limited - company overview including business description, key employees, and other facts.
- Review of current pipeline of Calzada Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, for the pharmaceutical markets across the globe.
- Product profiles for late stage and clinical stage products of Calzada Limited with complete description of the product’s developmental history, mechanism of action, clinical trials, major milestones and others.
- Recent updates of the Calzada Limited’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Calzada Limited’s strategic position with total access to a detailed intelligence on its product pipeline.
- Assess the growth potential of Calzada Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Calzada Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Calzada Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Calzada Limited and identify potential opportunities in those areas.
- Do deals with an understanding of the mergers and partnerships that have shaped the sector.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 list of Figures
2 INTRODUCTION
3 CALZADA LIMITED SNAPSHOT
3.1 Business Description
4 CALZADA LIMITED- RESEARCH AND DEVELOPMENT OVERVIEW
4.1 Key Therapeutic Areas
5 CALZADA LIMITED- PIPELINE REVIEW
5.1 Pipeline Products by Stage of Development
5.2 Pipeline Products-Monotherapy
5.3 Pipeline Products-Combination Treatment Modalities
6 CALZADA LIMITED PIPELINE PRODUCTS GLANCE
6.1 Calzada Limited Phase II Pipeline
6.2 Calzada Limited Phase I Pipeline
6.3 Calzada Limited Pre-Clinical Pipeline
7 CALZADA LIMITED - DRUG PROFILES
7.1 Product
7.1.1 Product Description
7.1.2 Mechanism of Action
7.1.3 R&D Progress
8 CALZADA LIMITED PIPELINE ANALYSIS
8.1 Calzada Limited Pipeline Products by Therapeutic Class
8.2 Calzada Limited Pipeline Products by Target
8.3 Calzada Limited Pipeline by Route of Administration
8.4 Calzada Limited Pipeline Products by Molecule Type
9 CALZADA LIMITED- RECENT PIPELINE UPDATES
10 CALZADA LIMITED- DORMANT PIPELINE PROJECTS
10.1 Feature on Dormant Projects
11 CALZADA LIMITED- DISCONTINUED PIPELINE PRODUCTS
11.1 Discontinued Pipeline Product Profiles
11.1.1 Product
12 CALZADA LIMITED – FEATURED NEWS
13 CALZADA LIMITED STATEMENT
13.1 Calzada Limited - Locations and Subsidiaries
14 APPENDIX
14.1 Global Markets Direct Research Methodology
14.2 Coverage
14.3 Secondary Research
14.4 Primary Research
14.5 Models
14.6 Expert Panels
14.7 Contact Us
14.8 Disclaimer
LIST OF TABLES
Table 1: Calzada Limited - Key Information
Table 2: Calzada Limited - Key Facts
Table 3: Calzada Limited - Key Therapeutic Areas
Table 4: Calzada Limited - Pipeline by Stage of Development,
Table 5: Calzada Limited - Monotherapy Products in Pipeline,
Table 6: Calzada Limited - Combination Treatment Modalities in Pipeline,
Table 7: Calzada Limited - Phase II Pipeline,
Table 8: Calzada Limited - Phase I Pipeline,
Table 9: Calzada Limited - Pre-Clinical Pipeline,
Table 10: Calzada Limited - Pipeline By Therapeutic Class
Table 11: Calzada Limited - Pipeline By Target
Table 12: Calzada Limited - Pipeline By Route of Administration
Table 13: Calzada Limited - Pipeline By Molecule Type
Table 14: Calzada Limited - Recent Pipeline Updates
Table 15: Calzada Limited - Dormant Pipeline Projects
LIST OF FIGURES
Figure 1: Calzada Limited - Research and Development Overview
Figure 2: Calzada Limited - Pipeline by Stage of Development,
Figure 3: Calzada Limited - Monotherapy Products in Pipeline,
Figure 4: Calzada Limited - Combination Treatment Modalities in Pipeline,
Figure 5: Calzada Limited - Pipeline By Therapeutic Class and Stage of Development
Figure 6: Calzada Limited - Pipeline By Therapeutic Class
Figure 7: Calzada Limited - Pipeline By Target and Stage of Development
Figure 8: Calzada Limited - Pipeline By Target
Figure 9: Calzada Limited - Pipeline By Route of Administration and Stage of Development
Figure 10: Calzada Limited - Pipeline By Route of Administration
Figure 11: Calzada Limited - Pipeline By Molecule Type and Stage of Development
Figure 12: Calzada Limited - Pipeline By Molecule Type
COMPANIES MENTIONED
Calzada Limited
1.1 List of Tables
1.2 list of Figures
2 INTRODUCTION
3 CALZADA LIMITED SNAPSHOT
3.1 Business Description
4 CALZADA LIMITED- RESEARCH AND DEVELOPMENT OVERVIEW
4.1 Key Therapeutic Areas
5 CALZADA LIMITED- PIPELINE REVIEW
5.1 Pipeline Products by Stage of Development
5.2 Pipeline Products-Monotherapy
5.3 Pipeline Products-Combination Treatment Modalities
6 CALZADA LIMITED PIPELINE PRODUCTS GLANCE
6.1 Calzada Limited Phase II Pipeline
6.2 Calzada Limited Phase I Pipeline
6.3 Calzada Limited Pre-Clinical Pipeline
7 CALZADA LIMITED - DRUG PROFILES
7.1 Product
7.1.1 Product Description
7.1.2 Mechanism of Action
7.1.3 R&D Progress
8 CALZADA LIMITED PIPELINE ANALYSIS
8.1 Calzada Limited Pipeline Products by Therapeutic Class
8.2 Calzada Limited Pipeline Products by Target
8.3 Calzada Limited Pipeline by Route of Administration
8.4 Calzada Limited Pipeline Products by Molecule Type
9 CALZADA LIMITED- RECENT PIPELINE UPDATES
10 CALZADA LIMITED- DORMANT PIPELINE PROJECTS
10.1 Feature on Dormant Projects
11 CALZADA LIMITED- DISCONTINUED PIPELINE PRODUCTS
11.1 Discontinued Pipeline Product Profiles
11.1.1 Product
12 CALZADA LIMITED – FEATURED NEWS
13 CALZADA LIMITED STATEMENT
13.1 Calzada Limited - Locations and Subsidiaries
14 APPENDIX
14.1 Global Markets Direct Research Methodology
14.2 Coverage
14.3 Secondary Research
14.4 Primary Research
14.5 Models
14.6 Expert Panels
14.7 Contact Us
14.8 Disclaimer
LIST OF TABLES
Table 1: Calzada Limited - Key Information
Table 2: Calzada Limited - Key Facts
Table 3: Calzada Limited - Key Therapeutic Areas
Table 4: Calzada Limited - Pipeline by Stage of Development,
Table 5: Calzada Limited - Monotherapy Products in Pipeline,
Table 6: Calzada Limited - Combination Treatment Modalities in Pipeline,
Table 7: Calzada Limited - Phase II Pipeline,
Table 8: Calzada Limited - Phase I Pipeline,
Table 9: Calzada Limited - Pre-Clinical Pipeline,
Table 10: Calzada Limited - Pipeline By Therapeutic Class
Table 11: Calzada Limited - Pipeline By Target
Table 12: Calzada Limited - Pipeline By Route of Administration
Table 13: Calzada Limited - Pipeline By Molecule Type
Table 14: Calzada Limited - Recent Pipeline Updates
Table 15: Calzada Limited - Dormant Pipeline Projects
LIST OF FIGURES
Figure 1: Calzada Limited - Research and Development Overview
Figure 2: Calzada Limited - Pipeline by Stage of Development,
Figure 3: Calzada Limited - Monotherapy Products in Pipeline,
Figure 4: Calzada Limited - Combination Treatment Modalities in Pipeline,
Figure 5: Calzada Limited - Pipeline By Therapeutic Class and Stage of Development
Figure 6: Calzada Limited - Pipeline By Therapeutic Class
Figure 7: Calzada Limited - Pipeline By Target and Stage of Development
Figure 8: Calzada Limited - Pipeline By Target
Figure 9: Calzada Limited - Pipeline By Route of Administration and Stage of Development
Figure 10: Calzada Limited - Pipeline By Route of Administration
Figure 11: Calzada Limited - Pipeline By Molecule Type and Stage of Development
Figure 12: Calzada Limited - Pipeline By Molecule Type
COMPANIES MENTIONED
Calzada Limited